Purchase Order 75N91019P00810

<p>The National Cancer Institute issued a purchase order to Gryphon Scientific, LLC for $24,100 on April 3, 2019, to identify biomarker signatures in the minipig model for different radiation doses and time points and annotate unannotated minipig probes. Work is performed in Bethesda, Maryland. The contract carries fixed-price pricing with economic price adjustment and has an ultimate completion date of April 2, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Gryphon Scientific, LLC valued at $38,200 for radiation inducible molecular targets identification after single and fractionated radiation in prostate carcinoma, with an award date of April 9, 2018 and ultimate completion date of April 9, 2019. Work is performed in Brookline, New Hampshire under firm fixed price terms with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Genus Biosystems Inc. valued at $57,268.80 on August 3, 2018, to test radiation-induced mRNAs in a mini pig model and determine whether these mRNAs can be used as organ-specific markers at various doses and time points. No set-aside applied. Work is performed in Northbrook, Illinois. The order is firm fixed price with an ultimate completion date of August 2, 2019.</p>

<p>The National Cancer Institute awarded a purchase order to Gryphon Scientific, LLC for $9,895.00 with a firm fixed price on July 26, 2017, with ultimate completion by August 28, 2017. No set-aside category was used. Place of performance is Beverly, Massachusetts. The source does not specify the procured items or services.</p>

<p>The National Cancer Institute awarded a purchase order to Gryphon Scientific, LLC for $13,340.00 on December 1, 2017, with an ultimate completion date of November 30, 2018. No set-aside was used. Performance will take place in Bethesda, Maryland. The order is priced as fixed price with economic price adjustment. Specific requirements are not detailed in the source.</p>

<p>The National Cancer Institute awarded a purchase order to Genus Biosystems Inc. valued at $55,879.20 on March 15, 2019, for identifying radiation-induced RNA markers in lung and liver tissue samples from whole-body irradiation studies. Work is performed in Northbrook, Illinois. The order carries a firm fixed price and was completed by August 15, 2019. The procurement originated from a special notice posted February 14, 2019, with a response deadline of February 28, 2019.</p>

<p>The National Cancer Institute awarded a purchase order to Genus Biosystems Inc. for $57,564.00 on September 17, 2018. The order, which carried no set-aside designation, covers exploration of gene expression and microRNA expression changes in tumors exposed to radiation, with and without specified treatment modalities. Work is performed in Northbrook, Illinois. The order is firm fixed price and carries an ultimate completion date of September 16, 2019.</p>

<p>The National Cancer Institute awarded a purchase order to Biocytogen LLC for $10,000.00 on April 3, 2018. Work is performed in Worcester, Massachusetts. The order carries a firm fixed price for commercial items, with ultimate completion on May 3, 2018. No small business set-aside was applied.</p>

<p>The National Cancer Institute issued a $24,966.43 delivery order to Government Scientific Source Inc. on May 17, 2021, under the GSA Multiple Award Schedule for scientific laboratory equipment.</p> <p>Place of performance is Reston, VA. The order carries a firm fixed price and an ultimate completion date of June 28, 2021.</p>

<p>The National Cancer Institute issued a $53,802 delivery order to Government Scientific Source Inc., a for-profit small business, on September 17, 2019, under the GSA Multiple Award Schedule (MAS) for Scientific Equipment and Services (FSS-66).</p> <p>Place of performance is Reston, VA. The order covers an ODYSSEY CLX Premium Bundle and is priced on a firm fixed-price basis. Ultimate completion date is December 23, 2019.</p>